CRISPR’s First Human Trial

16.11.2016.

A team of Chinese scientists has become the first to test CRISPR gene-edited cells in a human. The researchers, from Sichuan University in Chengdu, injected the cells into a patient with lung cancer. The experiment uses CRISPR — a cheap, easy, and accurate way to edit DNA in living cells—to disable a gene that suppresses immune response. By editing a small number of cells then growing them outside the body, the team was able to inject a large number back into the patient, with the intention of having them fight off the cancer. Human trials of CRISPR have been proposed in the U.S., but so far none have been carried out. Carl June, a researcher from the University of Pennsylvania who hopes to carry out some of the first such experiments in America, told Nature that he thinks that the news could “trigger ‘Sputnik 2.0’, a biomedical duel on progress between China and the United States.”

Experten- und Marktplattformen
Cloud Computing

Technologie-Basis zur Digitalisierung

mehr
Sicherheit und Datenschutz

Vertrauen zur Digitalisierung

mehr
Anwendungen

wichtige Schritte zur Digitalisierung

mehr
Digitale Transformation

Partner zur Digitalisierung

mehr
Energie

Grundlage zur Digitalisierung

mehr
Experten- und Marktplattformen
  • company
    Cloud Computing –

    Technologie-Basis zur Digitalisierung

    mehr
  • company
    Sicherheit und Datenschutz –

    Vertrauen zur Digitalisierung

    mehr
  • company
    Anwendungen –

    wichtige Schritte zur Digitalisierung

    mehr
  • company
    Digitale Transformation

    Partner zur Digitalisierung

    mehr
  • company
    Energie

    Grundlage zur Digitalisierung

    mehr
Blogs